MAD2L1 and breast carcinoma: (4) Some genes such as MAD2L1, RSL1D1, and CALCR were found to be significantly up-regulated in the tamoxifen-resistant cells, indicating that tamoxifen might not completely block the estrogen signaling in tamoxifen-resistant breast cancer cells.